Patent 10905637 was granted and assigned to Anterios on February, 2021 by the United States Patent and Trademark Office.
The present invention provides nanoparticle compositions including one or more peptides. The present invention achieves transdermal delivery of such peptides without the need for peptide modification, or for use of chemical or mechanical abrasion or disruption of skin.